- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05095935
Medtronic Signia SDR Product Surveillance Registry
February 8, 2023 updated by: Medtronic
Medtronic Signia Small Diameter Reload Product Surveillance Registry
The purpose of the registry is to confirm the safety and performance of the Signia™ Small Diameter Reload (SDR) when used in surgical procedures in a real-world setting in patients receiving surgery for indicated thoracic, abdominal, and pediatric applications, intraoperatively.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
340
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90048
- Recruiting
- Cedars Sinai Medical Center
-
-
Colorado
-
Denver, Colorado, United States, 80045
- Recruiting
- Children's Hospital Colorado
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Recruiting
- Rush
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Recruiting
- Cooper Health System
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- UNC Chapel Hill
-
Durham, North Carolina, United States, 27705
- Recruiting
- Duke University Health Systems
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Recruiting
- Cleveland Clinic
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- UPMC Falk Clinic
-
-
Texas
-
San Antonio, Texas, United States, 78249
- Recruiting
- University of Texas - San Antonio
-
-
Virginia
-
Fredericksburg, Virginia, United States, 22401
- Recruiting
- Mary Washington Hopital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing surgical procedures during which the Signia Small Diameter Reload is being used for transection of the arteries and veins meeting the cohort criteria.
Description
Inclusion Criteria:
- Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements
- Patient has, or is intended to receive or be treated with, an eligible Medtronic product
- Patient is consented within the enrollment window of the therapy received, as applicable
Exclusion Criteria:
- Patient who is, or is expected to be, inaccessible for follow-up
- Patient is excluded by local law
- Patient is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the PSR results
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Thoracic Adult
Use of Signia SDR for the transection of pulmonary arteries and veins in adult patients.
|
N/A observational registry
|
Abdominal Adult
Use of Signia SDR for the transection of renal arteries and veins in adult patients.
|
N/A observational registry
|
Abdominal Pediatric
Use of Signia SDR for the transection of the appendiceal stump and mesoappendix (simple acute appendicitis) in pediatric patients.
|
N/A observational registry
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of intraoperative hemostatic intervention
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incidence of repeat hospital admission for primary procedure-related complications
Time Frame: 30 days
|
30 days
|
|
Intraoperative assessments: Assessment of staple line integrity using a five-point Likert scale
Time Frame: 30 days
|
Range from 1 (no bleeding) to 5 (significant bleeding requiring intervention)
|
30 days
|
Intraoperative assessments: Incidence of staple line bleeding (measured as > 50cc)
Time Frame: 30 days
|
30 days
|
|
Intraoperative assessments: Additional intervention(s) to treat staple line failure
Time Frame: 30 days
|
Additional interoperative interventions to treat staple line failure (Applying additional stapler reloads, Applying compression greater than what is considered typical, Over-sewing with suture, Placing clips, Use of energy, Use of seatbelt, Other)
|
30 days
|
Post-operative assessments: Additional intervention(s) to treat staple-line failure
Time Frame: 30 days
|
Additional postoperative interventions to treat staple line failure (Applying additional stapler reloads, Applying compression greater than what is considered typical, Over-sewing with suture, Placing clips, Use of energy, Use of seatbelt, Other)
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
August 10, 2021
Primary Completion (ANTICIPATED)
April 1, 2025
Study Completion (ANTICIPATED)
July 1, 2025
Study Registration Dates
First Submitted
August 24, 2021
First Submitted That Met QC Criteria
October 25, 2021
First Posted (ACTUAL)
October 27, 2021
Study Record Updates
Last Update Posted (ESTIMATE)
February 9, 2023
Last Update Submitted That Met QC Criteria
February 8, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- Surgical PSR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Procedures, Operative
-
Nationwide Children's HospitalEnrolling by invitation
-
Wake Forest University Health SciencesMedtronic - MITGCompletedSurgical Procedures, OperativeUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Senthil G. KrishnaCompletedOperative Surgical ProceduresUnited States
-
Loma Linda UniversityCompletedSurgical Procedures, OperativeUnited States
-
Boston Children's HospitalCompletedSurgical Procedures, OperativeUnited States
-
University Hospital, Basel, SwitzerlandCompletedSurgical Procedures, OperativeSwitzerland
-
Murdoch Childrens Research InstituteBaylor College of Medicine; Children's Hospital of Philadelphia; University Hospital... and other collaboratorsCompletedSurgical Procedures, OperativeUnited States, Singapore, Australia
-
Loma Linda UniversityTerminatedSurgical Procedures, OperativeUnited States
Clinical Trials on N/A observational registry
-
University Health Network, TorontoRecruitingOsteo Arthritis Knee | Chronic Post-operative PainCanada
-
Uniformed Services University of the Health SciencesCenter for Neuroscience and Regenerative Medicine (CNRM)CompletedTBI (Traumatic Brain Injury)United States
-
Institute of Cancer Research, United KingdomTerminatedMetastatic Breast CancerUnited Kingdom
-
Ohio State UniversityUSDA North Central - Nutrition Education Center of ExcellenceCompleted
-
George Clinical Pty LtdActelion; The George InstituteCompletedTreatment Resistant Hypertension
-
Center for Eye Research AustraliaRecruitingAge-related Macular Degeneration | Geographic Atrophy | Age Related Macular Degeneration | AMDAustralia
-
University of California, San FranciscoNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
VASCage GmbHMedical University Innsbruck; St John of God Hospital, ViennaRecruiting
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
University College DublinUniversity College CorkCompletedFood Consumption Database AnalysisIreland